Dr Lisa J. Schmunk started her scientific journey in the University of Freiburg, Germany, where she obtained a first class honours and Master of Science degree in Biology. Specialising in Genetics and Synthetic Biology during her M.Sc., she was awarded the best foundational advance project prize in the iGEM competition 2013 for the application of the CRISPR/Cas9 system to epigenetic gene regulation (dCas9-KRAB/VP16). During her PhD at the University of Cambridge, Department of Public Health and Primary Care, Cardiovascular Epidemiology Unit, Lisa worked in the group of Prof. John Danesh and Prof. Nicole Soranzo on the genetic control of blood cell traits. She is now the Senior Research & Development Scientist at Hurdle (https://hurdle.bio/), where her team develops the latest suite of epigenetic ageing biomarkers, with a special interest in biological interpretability and accessibility.